NuCana plc (NCNA)

Etorro trading 970x250
NuCana plc (NCNA) Logo

About NuCana plc

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients with recurrent ovarian cancer; Phase III clinical trials for the treatment of patients with biliary tract cancer; Phase II clinical trial for the treatment of patients with platinum-resistant ovarian cancer; and Phase III clinical trial for the treatment of patients with metastatic pancreatic cancer. The company is also developing NUC-3373, a ProTide transformation of the active anti-cancer metabolite of 5-fluorouracil, which is in Phase I clinical trial for the treatment of patients with advanced solid tumors; and NUC-7738, a nucleoside analog that is in Phase I clinical trial for the treatment of patients with advanced solid tumors and hematological tumors. NuCana plc has a research, collaboration, and license agreement with Cardiff University and University College Cardiff Consultants Ltd. for the design, synthesis, characterization, and evaluation of ProTides; and an assignment, license, and collaboration agreement with Cardiff ProTides Ltd. The company was formerly known as NuCana BioMed Limited and changed its name to NuCana plc in August 2017. NuCana plc was incorporated in 1997 and is headquartered in Edinburgh, the United Kingdom. Address: 3 Lochside Way, Edinburgh, United Kingdom, EH12 9DT

NuCana plc News and around…

Latest news about NuCana plc (NCNA) common stock and company :

Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ...
28 Dec, 2021 Yahoo! Finance

Cambridge, MA, based Investment company Opaleye Management Inc. (Current Portfolio) buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics Pharmaceuticals Inc, Amicus Therapeutics Inc, Merus NV, sells ESSA Pharma Inc, Seres Therapeutics Inc, CM Life Sciences Inc, Lumos Pharma Inc, Kezar Life Sciences Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Opaleye Management Inc..

NuCana Reports Third Quarter 2021 Financial Results and Provides Business Update
18 Nov, 2021 Yahoo! Finance

Enrolled Required Number of Patients to Conduct First Interim Analysis in Phase 3 Biliary Tract Cancer Study in the First Half of 2022 Received Fast Track Designation from FDA for Acelarin for the Treatment of Patients with Biliary Tract Cancer Announced Additional Encouraging Clinical Data for NUC-3373 and NUC-7738 at ESMO Multiple Near-Term Study Initiations and Data Announcements Expected EDINBURGH, United Kingdom, Nov. 18, 2021 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced financia

NuCana to Present at the Jefferies 2021 London Healthcare Conference
10 Nov, 2021 Yahoo! Finance

EDINBURGH, United Kingdom, Nov. 10, 2021 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will present and host one-on-one meetings at the Jefferies 2021 London Healthcare Conference. Event: Jefferies 2021 London Healthcare ConferencePresentation Date: Wednesday, November 17, 2021Presentation Time: 4:20 PM GMT The presentation will be webcast live and available for replay under “Events & Presentatio

NuCana Appoints Elliott M. Levy, M.D. to its Board of Directors
01 Nov, 2021 Yahoo! Finance

Former Amgen SVP of Global Development and R&D Strategy and Operations Brings Substantial Drug Development Experience to NuCanaEDINBURGH, United Kingdom, Nov. 01, 2021 (GLOBE NEWSWIRE) -- NuCana plc (Nasdaq: NCNA), a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer announced the appointment of Elliott M. Levy, M.D. to its Board of Directors. Dr. Levy brings over 20 years of experience at global pharmaceutical companies, inclu

Here's Why We're Not At All Concerned With NuCana's (NASDAQ:NCNA) Cash Burn Situation
01 Nov, 2021 Yahoo! Finance

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

50 Biggest Movers From Yesterday
14 Oct, 2021 FinancialContent

Gainers Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares surged 105.1% to close at $14.79 on Wednesday after Oppenheimer initiated ...

51 Biggest Movers From Yesterday
01 Oct, 2021 FinancialContent

Gainers Superior Drilling Products, Inc. (NYSE: SDPI) shares rose 60.6% to close at $1.75 on Thursday after jumping over 23% on ...

12 Health Care Stocks Moving In Thursday's Intraday Session
30 Sep, 2021 FinancialContent

Gainers Progenity (NASDAQ:PROG) stock increased by 21.06% to $1.31 during Thursday's regular session. The current ...

36 Stocks Moving In Thursday's Mid-Day Session
30 Sep, 2021 FinancialContent

Gainers Paltalk, Inc. (NASDAQ: PALT) shares jumped 55% to $13.00. Paltalk engaged ClearThink to lead expanded investor relations ...

Company News for Sep 30, 2021
30 Sep, 2021 Yahoo! Finance

Companies in the news are: CTAS, NCNA, GOVX, LCID

12 Health Care Stocks Moving In Thursday's Pre-Market Session
30 Sep, 2021 FinancialContent

Gainers OptimizeRx (NASDAQ:OPRX) stock increased by 12.12% to $84.05 during Thursday's pre-market session. The ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
30 Sep, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! We're starting off your Thursday the right way with a look at the biggest pre-market stock movers for today! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

18 Stocks Moving in Thursday's Pre-Market Session
30 Sep, 2021 FinancialContent

Gainers Superior Drilling Products, Inc. (NYSE: SDPI) rose 58.7% to $1.73 in pre-market trading after jumping over 23% on ...

52 Biggest Movers From Yesterday
30 Sep, 2021 FinancialContent

Gainers Paltalk, Inc. (NASDAQ: PALT) shares jumped 60.1% to close at $8.39 on Wednesday. Smart Share Global Limited (NASDAQ: EM) ...

Mid-Afternoon Market Update: Dow Surges Over 200 Points; Neonode Shares Spike Higher
29 Sep, 2021 FinancialContent

Toward the end of trading Wednesday, the Dow traded up 0.67% to 34,531.13 while the NASDAQ climbed 0.33% to 14,594.58. The S&P also ...

6 Things for Potential PALT Stock Investors to Know About Social Video Play Paltalk as Shares Take Off
29 Sep, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Paltalk (PALT) is rocketing higher on Wednesday as traders flock to the stock following an update from the company today. The post 6 Things for Potential PALT Stock Investors to Know About Social Video Play Paltalk as Shares Take Off appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

12 Health Care Stocks Moving In Wednesday's Intraday Session
29 Sep, 2021 FinancialContent

Gainers NuCana (NASDAQ:NCNA) stock increased by 22.36% to $2.9 during Wednesday's regular session. The current ...

NCNA Stock: The Big Cancer Drug News Sending NuCana Skyrocketing
29 Sep, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips NuCana (NCNA) stock is surging higher on Wednesday after the company revealed fast track designation from the FDA for Acelarin. The post NCNA Stock: The Big Cancer Drug News Sending NuCana Skyrocketing appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

Mid-Day Market Update: Nasdaq Edges Lower; NuCana Shares Jump
29 Sep, 2021 FinancialContent

Midway through trading Wednesday, the Dow traded up 0.37% to 34,427.18 while the NASDAQ slipped 0.05% to 14,538.71. The S&P also ...

33 Stocks Moving In Wednesday's Mid-Day Session
29 Sep, 2021 FinancialContent

Gainers Paltalk, Inc. (NASDAQ: PALT) shares climbed 37% to $7.18. NuCana plc (NASDAQ: NCNA) jumped 31.4% to $3.1150. The FDA ...

Mid-Morning Market Update: Markets Open Higher; Jabil Reports Mixed Q1 Results
29 Sep, 2021 FinancialContent

Following the market opening Wednesday, the Dow traded up 0.45% to 34,453.66 while the NASDAQ rose 0.68% to 14,646.25. The S&P also ...

Why Are NuCana Shares Moving Higher On Wednesday?
29 Sep, 2021 FinancialContent

TheFDA has granted Fast Track designationtoNuCana plc's(NASDAQ: NCNA) Acelarin (NUC-1031) for the ...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
29 Sep, 2021 FinancialContent

Gainers Geovax Labs (NASDAQ:GOVX) shares increased by 23.44% to $5.16 during Wednesday's pre-market session. The ...

NuCana Receives Fast Track Designation from the U.S. Food and Drug Administration for Acelarin® (NUC-1031) for the Treatment of Biliary Tract Cancer
29 Sep, 2021 FinancialContent
NuCana Soars as FDA Fast Tracks Potential Drug for Biliary Tract Cancer
29 Sep, 2021 Yahoo! Finance

By Dhirendra Tripathi

NuCana Announces Four Poster Presentations at the ESMO Congress 2021
16 Sep, 2021 FinancialContent
NuCana Announces Enrollment of Required Number of Patients to Conduct First Interim Analysis in the Phase III Biliary Tract Cancer Study
15 Sep, 2021 FinancialContent
Analysts Anticipate IBB To Hit $199
13 Sep, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares Biotechnology ETF (IBB), we found that the implied analyst target price for the ETF based upon its underlying holdings is $198.82 per unit.

NuCana to Participate in Three Upcoming Investor Conferences
01 Sep, 2021 FinancialContent
7 Bargain Stocks to Buy Under $5 With the Right Catalysts
25 Aug, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips The risk in these inexpensive bargain stocks is offset by their upside for investors looking for a little more spice in their portfolio. The post 7 Bargain Stocks to Buy Under $5 With the Right Catalysts appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

NuCana plc (NCNA) is a NASDAQ Common Stock listed in , ,

970x250